Targeting innovation in antibiotics

Antimicrobial resistance (AMR) is currently responsible for over 700,000 deaths annually around the world. AMR mortality is predicted to rise exponentially to above 10 million deaths per year by 2050. The global economic cost of such a rise in mortality and morbidity is estimated to be $100 trillion